Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Brentuximab vedotin with AVD for stage II-IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trial.
Rubinstein PG, Moore PC, Bimali M, Lee JY, Rudek MA, Chadburn A, Ratner L, Henry DH, Cesarman E, DeMarco CE, Costagliola D, Taoufik Y, Ramos JC, Sharon E, Reid EG, Ambinder RF, Mitsuyasu R, Mounier N, Besson C, Noy A; AIDS Malignancy Consortium; Lymphoma Study Association. Rubinstein PG, et al. Among authors: bimali m. Lancet Haematol. 2023 Aug;10(8):e624-e632. doi: 10.1016/S2352-3026(23)00157-6. Lancet Haematol. 2023. PMID: 37532416 Clinical Trial.
The Role of Radiotherapy Among Patients With Prostate Ductal Adenocarcinoma.
Patel M, Bimali M, Howie C, McClain P, Mehta S, Harari M, Hans HS, Agarwal A, Pederson A, Maraboyina S, Kim T. Patel M, et al. Among authors: bimali m. Clin Genitourin Cancer. 2021 Feb;19(1):e41-e50. doi: 10.1016/j.clgc.2020.07.004. Epub 2020 Aug 3. Clin Genitourin Cancer. 2021. PMID: 33616071
The Use of Crowdfunding to Support Radiation Therapy Cancer Treatments.
Prabhu AV, Bimali M, Miljanic M, Kay H, Sandow L, Zhang M, Mumford K, Shah D, Clump DA, Skinner HD, Lewis GD. Prabhu AV, et al. Among authors: bimali m. Anticancer Res. 2021 Aug;41(8):3759-3767. doi: 10.21873/anticanres.15168. Anticancer Res. 2021. PMID: 34281835
Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status.
Baker D, Bimali M, Carrillo L, Sachedina A, Alapat D, Hoque MS, Kottarathara M, Parikh R, Erra A, Mitma AA, Mathur P, Ogunsesan Y, Yarlagadda L, Gundarlapalli S, Thanendrarajan S, Zangari M, Van Rhee F, Tricot G, Schinke C. Baker D, et al. Among authors: bimali m. Haematologica. 2021 Aug 12. doi: 10.3324/haematol.278779. Online ahead of print. Haematologica. 2021. PMID: 34382384
Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status.
Baker D, Bimali M, Carrillo L, Sachedina A, Alapat D, Hoque MS, Kottarathara M, Parikh R, Erra A, Mitma AA, Mathur P, Ogunsesan Y, Yarlagadda L, Gundarlapalli S, Thanendrarajan S, Zangari M, Van Rhee F, Tricot G, Schinke C. Baker D, et al. Among authors: bimali m. Haematologica. 2021 Dec 1;106(12):3215-3218. doi: 10.3324/haematol.2021.278779. Haematologica. 2021. PMID: 34847659 Free PMC article. No abstract available.
#Brachytherapy: Physicians As Influencers on Instagram.
Kesaria AZ, Bimali M, Patel M, Prabhu A, Kesaria S, Xia F. Kesaria AZ, et al. Among authors: bimali m. Cureus. 2022 Feb 23;14(2):e22524. doi: 10.7759/cureus.22524. eCollection 2022 Feb. Cureus. 2022. PMID: 35371782 Free PMC article.
30 results